2019
Sarcomas in the United States: Recent trends and a call for improved staging
Gage MM, Nagarajan N, Ruck JM, Canner JK, Khan S, Giuliano K, Gani F, Wolfgang C, Johnston FM, Ahuja N. Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget 2019, 10: 2462-2474. PMID: 31069009, PMCID: PMC6497437, DOI: 10.18632/oncotarget.26809.Peer-Reviewed Original ResearchCause-specific mortalityMultivariable logistic regression modelEpidemiology of sarcomasEnd Results (SEER) databaseAppropriate surgical treatmentPatterns of careCases of sarcomaMajority of tumorsStandardization of careLogistic regression modelsCommon histologySurgical treatmentHistologic typeOverall incidenceResults databaseSurgical interventionTrue incidenceImproved stagingSarcoma casesSarcomaPrimary siteComprehensive national studyTreatment factorsHeterogeneous groupTumors
2016
Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ?
Giuliano K, Nagarajan N, Canner J, Najafian A, Wolfgang C, Schneider E, Meyer C, Lennon AM, Johnston FM, Ahuja N. Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ? Journal Of Surgical Oncology 2016, 115: 351-357. PMID: 27885685, DOI: 10.1002/jso.24514.Peer-Reviewed Original ResearchConceptsSmall intestine gastrointestinal stromal tumorGastrointestinal stromal tumorsCause-specific mortalityGIST patientsDiagnosis of GISTCases of GISTLarge nation-wide studyGastric gastrointestinal stromal tumorsGastric GIST patientsCommon mesenchymal tumorsFive-year survivalApproval of imatinibNation-wide studySEER databaseStromal tumorsMesenchymal tumorsGastrointestinal tractAge 50PatientsSurvival analysisSimilar outcomesTumorsPrevious reportsFrequent useOutcomes